Mintz J - Search Results

1

Systematic dosage reduction in treatment-resistant schizophrenic patients.

Van Putten T, Marshall BD, Liberman R, Mintz J, Kuehnel TG, Bowen L, Aravagiri M, Marder SR. Van Putten T, et al. Among authors: mintz j. Psychopharmacol Bull. 1993;29(2):315-20. Psychopharmacol Bull. 1993. PMID: 7904763 Clinical Trial.

2

Technique for training schizophrenic patients in illness self-management: a controlled trial.

Eckman TA, Wirshing WC, Marder SR, Liberman RP, Johnston-Cronk K, Zimmermann K, Mintz J. Eckman TA, et al. Among authors: mintz j. Am J Psychiatry. 1992 Nov;149(11):1549-55. doi: 10.1176/ajp.149.11.1549. Am J Psychiatry. 1992. PMID: 1384364 Clinical Trial.

3

Acquisition and retention of skills training methods in chronic schizophrenic outpatients.

Wirshing WC, Marder SR, Eckman T, Liberman RP, Mintz J. Wirshing WC, et al. Among authors: mintz j. Psychopharmacol Bull. 1992;28(3):241-5. Psychopharmacol Bull. 1992. PMID: 1480726 Clinical Trial.

4

Haloperidol plasma levels and clinical response: a therapeutic window relationship.

Van Putten T, Marder SR, Mintz J, Poland RE. Van Putten T, et al. Among authors: mintz j. Am J Psychiatry. 1992 Apr;149(4):500-5. doi: 10.1176/ajp.149.4.500. Am J Psychiatry. 1992. PMID: 1554036 Clinical Trial.

5

Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.

Marder SR, Midha KK, Van Putten T, Aravagiri M, Hawes EM, Hubbard JW, McKay G, Mintz J. Marder SR, et al. Among authors: mintz j. Br J Psychiatry. 1991 May;158:658-65. doi: 10.1192/bjp.158.5.658. Br J Psychiatry. 1991. PMID: 1860020 Clinical Trial.

6

Early prediction of relapse in schizophrenia: an application of receiver operating characteristic (ROC) methods.

Marder SR, Mintz J, Van Putten T, Lebell M, Wirshing WC, Johnston-Cronk K. Marder SR, et al. Among authors: mintz j. Psychopharmacol Bull. 1991;27(1):79-82. Psychopharmacol Bull. 1991. PMID: 1862209 Clinical Trial.

7

Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients.

Van Putten T, Aravagiri M, Marder SR, Wirshing WC, Mintz J, Chabert N. Van Putten T, et al. Among authors: mintz j. Psychopharmacol Bull. 1991;27(2):91-6. Psychopharmacol Bull. 1991. PMID: 1924666 Clinical Trial.

8

Fluphenazine plasma levels and clinical response.

Marder SR, Van Putten T, Aravagiri M, Hawes EM, Hubbard JW, McKay G, Mintz J, Midha KK. Marder SR, et al. Among authors: mintz j. Psychopharmacol Bull. 1990;26(2):256-9. Psychopharmacol Bull. 1990. PMID: 2236467 Clinical Trial.

9

A controlled dose comparison of haloperidol in newly admitted schizophrenic patients.

Van Putten T, Marder SR, Mintz J. Van Putten T, et al. Among authors: mintz j. Arch Gen Psychiatry. 1990 Aug;47(8):754-8. doi: 10.1001/archpsyc.1990.01810200062009. Arch Gen Psychiatry. 1990. PMID: 2378546 Clinical Trial.

10

Adverse effects of fenfluramine in treatment refractory schizophrenia.

Marshall BD Jr, Glynn SM, Midha KK, Hubbard JW, Bowen LL, Banzett L, Mintz J, Liberman RP. Marshall BD Jr, et al. Among authors: mintz j. J Clin Psychopharmacol. 1989 Apr;9(2):110-5. doi: 10.1097/00004714-198904000-00007. J Clin Psychopharmacol. 1989. PMID: 2656778 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

555 results

Search Page

Filters